18 filings
8-K
ACRS
Aclaris Therapeutics Inc
3 Dec 19
Regulation FD Disclosure
12:00am
8-K
ACRS
Aclaris Therapeutics Inc
21 Nov 19
Regulation FD Disclosure
7:01am
8-K
ACRS
Aclaris Therapeutics Inc
7 Nov 19
Aclaris Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Highlights and an Update on R&D Programs
4:16pm
8-K
ACRS
Aclaris Therapeutics Inc
16 Oct 19
Entry into a Material Definitive Agreement
9:54pm
8-K
ACRS
Aclaris Therapeutics Inc
10 Oct 19
Entry into a Material Definitive Agreement
9:39pm
8-K
vql ni86bgju1
27 Sep 19
Regulation FD Disclosure
7:01am
8-K
7vu5csw3
9 Sep 19
Departure of Directors or Certain Officers
7:30am
8-K
mfe0v
5 Sep 19
Aclaris Therapeutics Announces New Strategic Direction
8:45am
8-K
w5mi485 3pkn
8 Aug 19
Undertaking strategic review of commercial and R&D assets
4:15pm
8-K
f48e8u0p3onw uhqq8n
30 Jul 19
Aclaris Therapeutics Announces Phase 2 Clinical Trial of ATI-501 Oral in Patients with Alopecia Areata Met Primary Endpoint
4:15pm
8-K
9rlgm30
3 Jul 19
Aclaris Therapeutics Announces Appointment of Maxine Gowen to Board of Directors
4:15pm
8-K
s11xln29
17 Jun 19
Regulation FD Disclosure
6:15am
8-K
ij6hvtf 8ua871
7 Jun 19
Departure of Directors or Certain Officers
7:00am
8-K
undz4cg23n207mt2g7
5 Jun 19
Regulation FD Disclosure
7:01am
8-K
3w03516
8 May 19
Aclaris Therapeutics Reports First Quarter 2019 Financial Results and Provides Update on Clinical and Commercial Developments
4:15pm
8-K
axz rf0yugh1e
4 Apr 19
Regulation FD Disclosure
7:06am
8-K
ifhc rjrm806tg5w
18 Mar 19
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Update on Clinical and Commercial Developments
7:15am
8-K
h2xr7zyt
8 Feb 19
Other Events
5:15pm
- Prev
- 1
- Next